Cargando…
Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19
Clinical presentations of COVID-19 are highly variable, yet the precise mechanisms that govern the pathophysiology of different disease courses remain poorly defined. Across the spectrum of disease severity, COVID-19 impairs both innate and adaptive host immune responses by activating innate immune...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250151/ https://www.ncbi.nlm.nih.gov/pubmed/34220859 http://dx.doi.org/10.3389/fimmu.2021.697405 |